Boehringer Ingelheim and MiNA Therapeutics to Develop Novel Treatment Approaches for Fibrotic Liver DiseasesCollaboration and Licensing Agreement • October 20th, 2021
Contract Type FiledOctober 20th, 2021• Collaboration and licensing agreement focused on investigating up to three targets and has a potential transactional value of up to EUR 307 million, excluding royalties